Lisa Rosenbaum.

It really is eminently quantifiable and yet stubbornly not. The purpose of widespread EHR adoption, as envisioned by the Obama administration in 2008, was allowing a transition from volume-structured to value-based payments: an electronic infrastructure was essential for measuring quality. At the time, however, significantly less than 17 percent of physician practices were using EHRs, and their systems often lacked necessary data-capture capabilities. Given the high up-front costs and uncertainty regarding future returns, financial and cultural hurdles to adoption were formidable.This collaboration exemplifies all the strategic elements we look for as we look for to broaden our business: a substantial unmet medical require, a commercially attractive market, and a terrific partner. Beneath the terms of the agreement, Gen-Probe shall be responsible for assay development, which 3M largely will fund. 3M will be responsible for integrating these assays onto one of its proprietary integrated device platforms, an easy-to-make use of molecular testing system that’s expected to generate results in less than one hour.